Cardiovascular
Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study
Oct
Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health. 2021;21(1):401.
Google Scholar
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.
Google Scholar
Saki N, Karandish M, Cheraghian B, Heybar H, Hashemi SJ, Azhdari M. Prevalence of cardiovascular diseases and associated factors among adults from southwest Iran: baseline data from Hoveyzeh Cohort Study. BMC Cardiovasc Disord. 2022;22(1):1–10.
Google Scholar
Ramezankhani A, Azizi F, Hadaegh F. Lifetime risk of cardiovascular disease stratified by traditional risk factors: findings from the cohort of Tehran lipid and glucose study. Hellenic J Cardiol. 2023;73:36–46.
Google Scholar
Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4):204–10.
Google Scholar
Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157–72.
Google Scholar
Wang Y-N, Ma S-X, Chen Y-Y, Chen L, Liu B-L, Liu Q-Q, et al. Chronic kidney disease: biomarker diagnosis to therapeutic targets. Clin Chim Acta. 2019;499:54–63.
Google Scholar
Bjornstad P, Karger AB, Maahs DM. Measured GFR in routine clinical practice—the promise of dried blood spots. Adv Chronic Kidney Dis. 2018;25(1):76–83.
Google Scholar
Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518–31.
Google Scholar
Heerspink HJL, Tighiouart H, Sang Y, Ballew S, Mondal H, Matsushita K, et al. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials. Am J Kidney Dis. 2014;64(6):860–6.
Google Scholar
Orlandi PF, Xie D, Yang W, Cohen JB, Deo R, Ricardo AC, et al. Slope of kidney function and its association with longitudinal mortality and cardiovascular disease among individuals with CKD. J Am Soc Nephrol. 2020;31(12):2912–23.
Google Scholar
Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, et al. Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data. J Am Soc Nephrol. 2019;30(9):1746–55.
Google Scholar
Oshima M, Jun M, Ohkuma T, Toyama T, Wada T, Cooper ME, et al. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study. Diabetologia. 2019;62(11):1988–97.
Google Scholar
El-Kebbi IM, Bidikian NH, Hneiny L, Nasrallah MP. Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action. World J Diabetes. 2021;12(9):1401.
Google Scholar
Ramezankhani A, Azizi F, Hadaegh F. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study. Cardiovasc Diabetol. 2022;21(1):227.
Google Scholar
Perkovic V, Agarwal R, Fioretto P, Hemmelgarn BR, Levin A, Thomas MC et al. Management of patients with diabetes and CKD: áconclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference. Kidney international. 2016;90(6):1175-83.
Li H, Lu W, Wang A, Jiang H, Lyu J. Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: estimates from global burden of Disease 2017. J Diabetes Invest. 2021;12(3):346–56.
Google Scholar
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.
Google Scholar
Hubbard D, Colantonio LD, Rosenson RS, Brown TM, Jackson EA, Huang L, et al. Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease. Cardiovasc Diabetol. 2021;20(1):58.
Google Scholar
Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10(1):1–15.
Google Scholar
Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an iranian urban population: Tehran lipid and glucose study (phase 1). Sozial-und präventivmedizin. 2002;47:408–26.
Google Scholar
Sardarinia M, Asgari S, Hizomi Arani R, Eskandari F, Azizi F, Khalili D, et al. Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: more than a decade follow up in the Tehran lipids and glucose study. J Diabetes Invest. 2022;13(2):317–27.
Google Scholar
Nelson RG, Grams ME, Ballew SH, Sang Y, Azizi F, Chadban SJ, et al. Development of risk prediction equations for incident chronic kidney disease. JAMA. 2019;322(21):2104–14.
Google Scholar
Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766–72.
Google Scholar
Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH et al. /ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2018;71(19):e127-e248.
Khalili D, Azizi F, Asgari S, Zadeh-Vakili A, Momenan AA, Ghanbarian A et al. Outcomes of a longitudinal population-based cohort study and pragmatic community trial: findings from 20 years of the Tehran lipid and glucose study. Int J Endocrinol Metabolism. 2018;16(4 Suppl).
Verbeke G, Molenberghs G, Rizopoulos D. Random effects models for longitudinal data. Longitudinal research with latent variables: Springer; 2010. pp. 37–96.
Janmaat CJ, van Diepen M, Tsonaka R, Jager KJ, Zoccali C, Dekker FW. Pitfalls of linear regression for estimating slopes over time and how to avoid them by using linear mixed-effects models. Nephrol Dialysis Transplantation. 2019;34(4):561–6.
Google Scholar
Carracedo J, Alique M, Vida C, Bodega G, Ceprián N, Morales E, et al. Mechanisms of Cardiovascular Disorders in patients with chronic kidney disease: a process related to Accelerated Senescence. Front cell Dev Biology. 2020;8:185.
Google Scholar
Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1–3):84–92.
Google Scholar
Rajagopal K, Karthikeyan A. Complex dynamics in a fractional order nephron pressure and flow regulation model. Bio Syst. 2023;230:104931.
Google Scholar
Dube P, DeRiso A, Patel M, Battepati D, Khatib-Shahidi B, Sharma H et al. Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall. 2021;9(4).
Warren B, Rebholz CM. Diabetes and trajectories of estimated glomerular filtration rate: a prospective cohort analysis of the atherosclerosis risk in Communities Study. Diabetes Care. 2018;41(8):1646–53.
Google Scholar
Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, van Raalte DH, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28(4):1023–39.
Google Scholar
Yang Y, Xu G. Update on pathogenesis of glomerular hyperfiltration in Early Diabetic kidney disease. Front Endocrinol. 2022;13:872918.
Google Scholar
Yau K, Dharia A, Alrowiyti I, Cherney DZI. Prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations. Kidney Int Rep. 2022;7(7):1463–76.
Google Scholar
Triozzi JL, Parker Gregg L, Virani SS, Navaneethan SD. Management of type 2 diabetes in chronic kidney disease. BMJ Open Diabetes Research & Care. 2021;9(1).
Moazzeni SS, Hizomi Arani R, Deravi N, Hasheminia M, Khalili D, Azizi F, et al. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran lipid and glucose study. Cardiovasc Diabetol. 2021;20(1):141.
Google Scholar
Melsom T, Nair V, Schei J, Mariani L, Stefansson VTN, Harder JL, et al. Correlation between baseline GFR and subsequent change in GFR in norwegian adults without diabetes and in Pima Indians. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2019;73(6):777–85.
Google Scholar
Ko GJ, Rhee CM, Kalantar-Zadeh K, Joshi S. The Effects of high-protein diets on kidney health and longevity. J Am Soc Nephrol. 2020;31(8):1667–79.
Google Scholar
Borrelli S, Provenzano M. Sodium intake and chronic kidney disease. Int J Mol Sci. 2020;21(13).
Turin TC, Jun M, James MT, Tonelli M, Coresh J, Manns BJ, et al. Magnitude of rate of change in kidney function and future risk of cardiovascular events. Int J Cardiol. 2016;202:657–65.
Google Scholar
Ragot S, Saulnier PJ, Velho G, Gand E, de Hauteclocque A, Slaoui Y, et al. Dynamic changes in renal function are Associated with Major Cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2016;39(7):1259–66.
Google Scholar
Nagai K, Yamagata K, Ohkubo R, Saito C, Asahi K, Iseki K, et al. Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria. Nephrology. 2014;19(9):574–80.
Google Scholar
Guo Y, Cui L, Ye P, Li J, Wu S, Luo Y. Change of kidney function is associated with all-cause mortality and cardiovascular diseases: results from the kailuan study. J Am Heart Association. 2018;7(21):e010596.
Google Scholar
Van Pottelbergh G, Mamouris P, Opdeweegh N, Vaes B, Goderis G, Van Den Akker M. Is there a correlation between an eGFR slope measured over a 5-year period and incident cardiovascular events in the following 5 years among a flemish general practice population: a retrospective cohort study. BMJ open. 2018;8(11):e023594.
Google Scholar
Suchy-Dicey AM, Zhang Y, McPherson S, Tuttle KR, Howard BV, Umans J, et al. Glomerular filtration function decline, mortality, and cardiovascular events: data from the strong heart study. Kidney360. 2021;2(1):71–8.
Google Scholar
van Rijn MHC, Metzger M, Flamant M, Houillier P, Haymann JP, van den Brand J, et al. Performance of creatinine-based equations for estimating glomerular filtration rate changes over time. Nephrol Dial Transplant. 2020;35(5):819–27.
Google Scholar
Gaspari F, Ruggenenti P, Porrini E, Motterlini N, Cannata A, Carrara F, et al. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int. 2013;84(1):164–73.
Google Scholar
Nichols GA, Déruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes. BMC Nephrol. 2020;21(1):167.
Google Scholar
Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, et al. Change in Albuminuria and GFR as End points for clinical trials in early stages of CKD: A Scientific Workshop Sponsored by the national kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency. Am J Kidney Dis. 2020;75(1):84–104.
Google Scholar
